|
EP2477640A2
|
|
Methods of treating a patient receiving a cardiac stent implant
|
|
AU2008200257A1
|
|
Nucleic acid molecules and polypeptides for immune modulation
|
|
US2009011979A1
|
|
Immunomodulatory protein and useful embodiments thereof
|
|
US2006122115A1
|
|
Use of SERP-1 as an antiplatelet agent
|
|
JP2005306883A
|
|
Antirestenosis protein
|
|
US2003171263A1
|
|
Methods for treating transplant rejection
|
|
EP1834960A2
|
|
Immunomodulatory protein derived from the yaba monkey tumor virus
|
|
AU2002211744B2
|
|
Nucleic acid molecules and polypeptides for immune modulation
|
|
EP1365798A2
|
|
Use of serp-1 in combination with an immunosuppressant for treating arthritis
|
|
WO0187324A1
|
|
Compositions and methods for promoting immunosuppression
|
|
AU1943501A
|
|
Methods of treating inflammation and compositions therefor
|
|
AU6175000A
|
|
Novel myxoma genes for immune modulation
|
|
US6589933B1
|
|
Myxoma chemokine binding protein
|
|
US6495515B1
|
|
Chemokine binding protein and methods of use therefor
|
|
US5939525A
|
|
Methods of treating inflammation and compositions therefor
|
|
EP0754054A1
|
|
Antirestenosis protein
|
